SHARE
Antibiotics Market

Antibiotics - Global Market Outlook (2020-2028)

4.8 (69 reviews)
Published: April 2021 ID: SMRC20394
4.8 (69 reviews)
Published: April 2021 ID: SMRC20394

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global Antibiotics Market is accounted for $40.70 billion in 2020 and is expected to reach $67.36 billion by 2028 growing at a CAGR of 6.5% during the forecast period. The rising prevalence of infectious diseases, supportive government legislation and the expanding vulnerable aging population are driving the market growth. However, some issues associated with antibiotics, such as antibiotic resistance and lengthy and tedious regulatory procedures is hampering the growth of the market.

Antibiotic is a medication used to either inhibit or prevent bacterial infections referred as bactericidal and bacteriostatic antibiotics, respectively. Various types of antibiotics such as penicillin, cephalosporin, carbapenem, and monobactam are available in pharmacies and hospitals that are used to treat infectious diseases.

Based on the drug class, the penicillin segment is going to have lucrative growth during the forecast period due to maximum prescription and the largest number of generic manufacturers in the space. By geography, Asia Pacific is going to have high growth during the forecast period owing to the high consumption of antibiotics, increase in the prevalence of infectious diseases, and rising government initiatives to develop novel therapies to treat drug-resistant infections in the region.

Some of the key players profiled in the Antibiotics Market include Abbott Laboratories, AbbVie Inc., Astellas Pharma, AstraZeneca Plc, Bayer AG, Daiichi Sankyo, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Mayne Pharma Group Ltd., Melinta Therapeutics Inc., Merck KGaA, Pfizer Inc. and Sanofi.

Action Mechanisms Covered:
• Bacteriostatic
• Bactericidal

Inhibitors Covered:
• Cell Wall Synthesis Inhibitors
• DNA Synthesis Inhibitors
• Mycolic Acid Inhibitors
• Protein Synthesis Inhibitors
• RNA Synthesis Inhibitors    

Spectrums Covered:
• Broad Spectrum
• Narrow Spectrum

Route of Administrations Covered:
• Inhalation
• Intravenous
• Oral
• Parenteral
• Sublingual
• Topical

Indications Covered:
• Blood Stream Infections
• Clostridium Difficile Infections
• Intra-Abdominal Infections
• Urinary Tract Infection

Origins Covered:
• Natural
• Semisynthetic
• Synthetic

Drug Classes Covered:
• 7-ACA
• Aminoglycoside
• Beta Lactam &Beta Lactamase Inhibitors
• Carbapenem
• Cephalosporin
• Fluoroquinolone
• Imidazole
• Lincosamide
• Macrolide
• Monoclonal Antibodies
• Penicillin
• Phenicols
• Quinolone/Fluoroquinolone
• Sulfonamide
• Tetracycline

Applications Covered:
• Human
• Veterinary

End Users Covered:
• Hospitals
• Homecare
• Specialty Clinics
• Research Organizations

Distribution Channels Covered:
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials